AcelRx Pharmaceuticals (ACRX) Stock: Why It Skyrocketed Over 70% Today

By Amit Chowdhry ● Aug 11, 2022
  • The stock price of AcelRx Pharmaceuticals (ACRX) skyrocketed over 70% pre-market today. This is why.

The stock price of AcelRx Pharmaceuticals (ACRX) – a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings – skyrocketed over 70% pre-market today. Investors are responding positively to AcelRx Pharmaceuticals announcing that an abstract titled “The Impact of Sublingual Sufentanil on Postoperative Pain Control in Patients Undergoing Spine Surgery” (abstract # A4262) was accepted for e-Abstract presentation at the ANESTHESIOLOGY® 2022 annual meeting, being held October 21-25, 2022 in New Orleans, LA.

The E-Abstracts will be presented virtually and made available to registrants throughout the entire meeting from Saturday, October 22 (7:00 a.m. US Central Time) to Tuesday, October 25, 2022 (3:00 p.m. U.S. Central Time). The abstracts will remain available and open to meeting attendees for three months after the meeting.